FDC

{
  "main_header": {
    "sid": 248455,
    "name": "FDC",
    "stock_name": "FDC",
    "full_name": "FDC Ltd",
    "name_url": "stocks-analysis/fdc",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "370.00",
    "chg": -17.55,
    "chgp": "-4.53%",
    "dir": -1,
    "prev_price": "387.55",
    "mcapval": "6,178.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531599,
    "symbol": "FDC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE258B01022",
    "curr_date": "Aug 06, 03:30 PM",
    "curr_time": "20:43 PM",
    "last_traded_at": "Aug 06, 03:30 PM IST",
    "bse_nse_vol": "8.95 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 06, 2026",
    "traded_date_str": "2026 08 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are FDC Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fdc-ltd-latest-results-good-or-bad-4140350",
        "imagepath": "",
        "date": "2026-08-06 19:21:13",
        "description": "FDC Ltd's latest financial results for Q1 FY27 reveal a company experiencing notable operational momentum in the short term, with net profit reaching ₹132.49 crores, reflecting a 28.13% increase compared to the previous quarter. Revenue also demonstrated growth, climbing to ₹667.69 crores, which represents a 14.18% sequential rise. The operating margin, excluding other income, improved to 21.42%, indicating enhanced cost management and operational efficiency.\n\nDespite these positive quarterly results, the year-on-year revenue growth moderated to 2.97%, suggesting challenges in sustaining momentum compared to the same period last year. The company's net profit margin improved to 19.84%, driven by operational leverage and a favorable tax rate, which is a significant achievement compared to previous quarters.\n\nHowever, FDC's historical performance shows considerable margin volatility, with operating margins fl..."
      },
      {
        "title": "FDC Ltd Valuation Shifts to Fair: A Detailed Analysis of Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-to-fair-a-detailed-analysis-of-price-attractiveness-4138991",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FDCLtd_valuationdot_4138991.png",
        "date": "2026-08-06 08:00:24",
        "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, reflects evolving market perceptions and presents a nuanced picture for investors assessing price attractiveness against sector peers and historical benchmarks."
      },
      {
        "title": "FDC Ltd Q1 FY27: Stellar Profit Surge Masks Margin Volatility Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/fdc-ltd-q1-fy27-stellar-profit-surge-masks-margin-volatility-concerns-4138567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/FDC_quaterlyResult_4138567.png",
        "date": "2026-08-05 21:16:10",
        "description": "FDC Ltd., a fully integrated research-oriented pharmaceutical company specialising in formulations and active pharmaceutical ingredients, reported a robust 28.13% quarter-on-quarter surge in net profit to ₹132.49 crores for Q1 FY27, up from ₹103.40 crores in Q4 FY26. On a year-on-year basis, the company posted a 9.17% increase from ₹121.36 crores in Q1 FY26. Despite the impressive profit growth, the stock tumbled 3.85% to ₹387.50 on August 05, 2026, reflecting investor concerns over historical margin inconsistency and persistent underperformance against benchmark indices."
      },
      {
        "title": "FDC Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-hold-by-marketsmojo-4124054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/FDCLtd_mojoScore_4124054.png",
        "date": "2026-07-28 10:11:13",
        "description": "FDC Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for FDC Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-fdc-ltd-4119868",
        "imagepath": "",
        "date": "2026-07-24 23:16:59",
        "description": "The next results date for FDC Ltd is scheduled for 05 August 2026...."
      },
      {
        "title": "FDC Ltd Valuation Shifts to Fair, Enhancing Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-to-fair-enhancing-price-attractiveness-amid-sector-challenges-4118450",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/FDCLtd_valuationdot_4118450.png",
        "date": "2026-07-24 08:00:19",
        "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This transition, driven by changes in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a detailed analysis of its price attractiveness relative to historical levels and peer companies within the sector."
      },
      {
        "title": "FDC Ltd Declines 2.85% Amid Mixed Technical Signals and Golden Cross Formation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-declines-285-amid-mixed-technical-signals-and-golden-cross-formation-4108120",
        "imagepath": "",
        "date": "2026-07-19 12:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Stock opens at Rs.428.50, declines 0.81%</p>\n                    <p><strong>14 Jul:</strong> Further decline to Rs.421.55 (-1.62%) amid mixed technical momentum</p>\n                    <p><strong>15 Jul:</strong> Technical momentum shifts to mildly bearish; stock closes at Rs.424.40 (+0.68%)</p>\n                    <p><strong>16 Jul:</strong> Golden Cross forms; Mojo Grade upgraded to Hold; stock closes at Rs.421.90 (-0.59%)</p>\n                    <p><strong>17 Jul:</strong> Technical momentum shifts mildly bullish; stock closes at Rs.419.70 (-0.52%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><di..."
      },
      {
        "title": "FDC Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-financials-4105748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/FDCLtd_mojoScore_4105748.png",
        "date": "2026-07-17 08:02:15",
        "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and a return to positive financial performance. The MarketsMOJO Mojo Score now stands at 58.0, signalling cautious optimism amid mixed long-term fundamentals and valuation concerns."
      },
      {
        "title": "FDC Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-amid-mixed-indicators-4105614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/FDCLtd_technicaldot_4105614.png",
        "date": "2026-07-17 08:00:27",
        "description": "FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in the latest session, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, suggesting cautious optimism for investors analysing its near-term prospects."
      }
    ],
    "total": 263,
    "sid": "248455",
    "stock_news_url": "https://www.marketsmojo.com/news/fdc-248455"
  },
  "announcements": [
    {
      "details": "FDC Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "FDC Limited - Clarification - Financial Results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "FDC Limited has informed the Exchange regarding 'Acquisition of Registered Trademark/ Brand \"ENTEROPLUS\" from GlaxoSmithKline Pharmaceuticals Limited (GSK)'.",
      "source": "NSE",
      "caption": "FDC Limited - Updates",
      "datetime": "18-Oct-2019"
    },
    {
      "details": "FDC Limited has informed the Exchange regarding 'Certificate in terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 ( said regulations ) on behalf of FDC Limited ( the Company ) for the quarter ended on September 30, 2019'.'.",
      "source": "NSE",
      "caption": "FDC Limited - Updates",
      "datetime": "16-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 11 Feb 26",
          "dt": "2026-02-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are FDC Ltd latest results good or bad?

2026-08-06 19:21:13

FDC Ltd's latest financial results for Q1 FY27 reveal a company experiencing notable operational momentum in the short term, with net profit reaching ₹132.49 crores, reflecting a 28.13% increase compared to the previous quarter. Revenue also demonstrated growth, climbing to ₹667.69 crores, which represents a 14.18% sequential rise. The operating margin, excluding other income, improved to 21.42%, indicating enhanced cost management and operational efficiency. Despite these positive quarterly results, the year-on-year revenue growth moderated to 2.97%, suggesting challenges in sustaining momentum compared to the same period last year. The company's net profit margin improved to 19.84%, driven by operational leverage and a favorable tax rate, which is a significant achievement compared to previous quarters. However, FDC's historical performance shows considerable margin volatility, with operating margins fl...

Read full news article

FDC Ltd Valuation Shifts to Fair: A Detailed Analysis of Price Attractiveness

2026-08-06 08:00:24

FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, reflects evolving market perceptions and presents a nuanced picture for investors assessing price attractiveness against sector peers and historical benchmarks.

Read full news article

FDC Ltd Q1 FY27: Stellar Profit Surge Masks Margin Volatility Concerns

2026-08-05 21:16:10

FDC Ltd., a fully integrated research-oriented pharmaceutical company specialising in formulations and active pharmaceutical ingredients, reported a robust 28.13% quarter-on-quarter surge in net profit to ₹132.49 crores for Q1 FY27, up from ₹103.40 crores in Q4 FY26. On a year-on-year basis, the company posted a 9.17% increase from ₹121.36 crores in Q1 FY26. Despite the impressive profit growth, the stock tumbled 3.85% to ₹387.50 on August 05, 2026, reflecting investor concerns over historical margin inconsistency and persistent underperformance against benchmark indices.

Read full news article

FDC Ltd is Rated Hold by MarketsMOJO

2026-07-28 10:11:13

FDC Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for FDC Ltd?

2026-07-24 23:16:59

The next results date for FDC Ltd is scheduled for 05 August 2026....

Read full news article

FDC Ltd Valuation Shifts to Fair, Enhancing Price Attractiveness Amid Sector Challenges

2026-07-24 08:00:19

FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This transition, driven by changes in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a detailed analysis of its price attractiveness relative to historical levels and peer companies within the sector.

Read full news article

FDC Ltd Declines 2.85% Amid Mixed Technical Signals and Golden Cross Formation

2026-07-19 12:00:06

Key Events This Week

13 Jul: Stock opens at Rs.428.50, declines 0.81%

14 Jul: Further decline to Rs.421.55 (-1.62%) amid mixed technical momentum

15 Jul: Technical momentum shifts to mildly bearish; stock closes at Rs.424.40 (+0.68%)

16 Jul: Golden Cross forms; Mojo Grade upgraded to Hold; stock closes at Rs.421.90 (-0.59%)

17 Jul: Technical momentum shifts mildly bullish; stock closes at Rs.419.70 (-0.52%)

Read full news article

FDC Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials

2026-07-17 08:02:15

FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and a return to positive financial performance. The MarketsMOJO Mojo Score now stands at 58.0, signalling cautious optimism amid mixed long-term fundamentals and valuation concerns.

Read full news article

FDC Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook Amid Mixed Indicators

2026-07-17 08:00:27

FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a slight dip in the latest session, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, suggesting cautious optimism for investors analysing its near-term prospects.

Read full news article

View All News